This Data Signals The End For Merck's Anacetrapib
April 04, 2016 at 11:33 AM EDT
The ACCELERATE study data for Evacetrapib, which is a selective inhibitor of cholesteryl ester transfer protein [CETP] of Eli Lilly ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.